Panel Supports Smith & Nephew’s Birmingham Hip Resurfacing System

FDA's Orthopaedic & Rehabilitation Devices Panel narrowly recommended approval for Smith & Nephew's Birmingham Hip Resurfacing system Sept. 8, provided that the firm conducts a postmarket study

More from Archive

More from Medtech Insight